Orange SA’s shares have declined 12% over the past three months, underperforming peers amid a broader market pullback in European telecoms. The stock last traded at €15.64 on Sept. 3, 2026, near the lower end of its 52-week range of €13.08 to €18.81.
Analysts at UBS and InvestingPro argue the dip presents a buying opportunity, citing the company’s robust financial position. UBS maintained a €21.50 target price on Orange, implying a potential 37% upside from current levels. InvestingPro’s fair-value estimate stands at €16.99, suggesting an 8.6% premium to the market price.
The telecom operator reported second-quarter earnings that exceeded expectations by 185.71%, triggering a 6% share-price gain on July 28. Despite the positive surprise, Orange’s stock has since retraced, with a one-month return of -5.81% and a three-month decline of 11.66%. Year-over-year, shares remain up 15.64%.
Orange’s fundamentals remain solid. Revenue grew 3% year-over-year to €40.40 billion in 2025, up from €39.13 billion in 2022. EBITDA reached €12.10 billion, while levered free cash flow totaled €5.03 billion. Total debt stood at €56.75 billion as of June 30, 2026. The company offers a trailing dividend yield of 4.8%, supported by its cash-generation capacity.
Technical indicators present a mixed signal. Daily metrics show a sell rating, while weekly and monthly signals diverge, with weekly marked as a strong sell and monthly as a buy. The weekly relative strength index (RSI) is at 42.654, and the monthly RSI stands at 58.728. The weekly MACD remains negative, though weekly support is identified at €14.61.
UBS analysts described Orange as a defensive growth story with material free-cash-flow and shareholder-return potential, recommending investors consider the current valuation as an entry point. The next earnings release is scheduled for Oct. 27, 2026.
